70121-2701 Oziltus - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

70121-2701

Brand Name:

Oziltus

Generic Name:

Denosumab-mobz

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Subcutaneous

Substances:

Name: DENOSUMAB

Strength: 70.0

Unit: mg/mL

Packages:

Code: 70121-2701-01

Description: 1 VIAL in 1 CARTON (70121-2701-1) / 1.7 mL in 1 VIAL

Effective Date: Dec. 23, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

RANKL

Orphan Drug Designation:

Status:

In Use